Examining the Feasibility of an Internet-Delivered Cognitive Behaviour Therapy program for emotional wellbeing among people with epilepsy.
- Conditions
- EpilepsyAnxietyDepressionMental Health - DepressionMental Health - AnxietyNeurological - Epilepsy
- Registration Number
- ACTRN12614001300662
- Lead Sponsor
- Dr Milena Gandy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
18+ years of age.
- Confirmed diagnosis of epilepsy; which is being managed by a GP or specialist.
- Living in Australia.
- Has had a recent consultation (i.e., in the last 6 months) with a GP or specialist.
- Provide informed consent to participate in the study.
- Inability to use a computer.
- Severe depression (i.e., indicated by a score > 22 on the PHQ-9).
- Significant suicidal ideation (i.e., indicated by a score > 2 to Question 9 of the PHQ-9).
- Acutely suicidal or recent history of attempted suicide or self-harm (i.e., last 12 months).
- Serious cognitive impairment or dementia (<21 on the Telephone Interview of Cognitive Status; TICS).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient Health Questionnaire 9-Item (PHQ9) and Neurological Depressive Disorders Inventory for Epilepsy (NDDI-E), which are two measures of depression.[Application, pre-treatment, weekly during treatment (PHQ-9), post-treatment and 3 month follow-up.<br>];Generalized Anxiety Disorder 7-Item (GAD7), which is a measure of anxiety.<br>[Application, pre-treatment, weekly during treatment, post-treatment and 3 month follow-up.<br>];World Health Organisation Disability Assessment Schedule 2.0 (WHODAS-2), which is a measure of disability associated with living with a chronic health condition. [Pre-treatment, post-treatment and 3 month follow-up.]
- Secondary Outcome Measures
Name Time Method